Literature DB >> 20056846

Role of sympathetic responses on the hemodynamic consequences of rapid changes in posture in humans.

Don D Sheriff1, Inger Helene Nådland, Karin Toska.   

Abstract

Tolerance to +G(z) gravitational stress is reduced when +G(z) stress is preceded by exposure to hypogravity (fractional, 0, or negative G(z)). For example, there is an exaggerated fall in eye-level arterial pressure (ELAP) early on during +G(z) stress (head-up tilt; HUT) when this stress is immediately preceded by -G(z) stress (head-down tilt; HDT), termed the "push-pull effect." The aim of the present study was to test the hypothesis that sympathetic responses contribute to the push-pull effect. Young, healthy subjects (n = 7 males and 3 females) were subjected to 30 s of 30 degrees HUT from a horizontal position and to 30 s of 30 degrees HUT when HUT was immediately preceded by 20 s of -15 degrees HDT. Four bouts of HDT-HUT were alternated between five bouts of HUT in a counterbalanced design, and 1 min was allowed for recovery between tilts. This protocol was repeated during clonidine administration (2.5 microg/kg bolus over 30 min and then continuously at 0.36 microg x kg(-1) x h(-1)). Clonidine blunted the vasomotor responses to tilting, and this led to exaggerated changes in arterial pressure. Clonidine exerted little specific influence on the push-pull effect. Thus sympathetic responses appear neither to contribute to, nor protect against, the push-pull effect for the rate and duration of tilting imposed in the present study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056846     DOI: 10.1152/japplphysiol.01185.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  12 in total

Review 1.  Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment.

Authors:  Li-Fan Zhang
Journal:  Eur J Appl Physiol       Date:  2013-03-24       Impact factor: 3.078

Review 2.  Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

Authors:  Michael Gutkin; Julian M Stewart
Journal:  Am J Hypertens       Date:  2016-04-01       Impact factor: 2.689

3.  The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.

Authors:  Julian M Stewart; Archana Kota; Mary Breige O'Donnell-Smith; Paul Visintainer; Courtney Terilli; Marvin S Medow
Journal:  J Appl Physiol (1985)       Date:  2020-07-23

4.  Prior head-down tilt does not impair the cerebrovascular response to head-up tilt.

Authors:  Changbin Yang; Yuan Gao; Danielle K Greaves; Rodrigo Villar; Thomas Beltrame; Katelyn S Fraser; Richard L Hughson
Journal:  J Appl Physiol (1985)       Date:  2015-03-06

5.  The Benefits of Oral Rehydration on Orthostatic Intolerance in Children with Postural Tachycardia Syndrome.

Authors:  Marvin S Medow; Kenneth Guber; Shilpan Chokshi; Courtney Terilli; Paul Visintainer; Julian M Stewart
Journal:  J Pediatr       Date:  2019-08-09       Impact factor: 4.406

6.  Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome.

Authors:  Andrew T Del Pozzi; Christopher E Schwartz; Deepali Tewari; Marvin S Medow; Julian M Stewart
Journal:  Hypertension       Date:  2014-04-07       Impact factor: 10.190

7.  Postural Heart Rate Changes in Young Patients With Vasovagal Syncope.

Authors:  Marvin S Medow; Sana Merchant; Melissa Suggs; Courtney Terilli; Breige O'Donnell-Smith; Julian M Stewart
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 8.  Mechanisms of sympathetic regulation in orthostatic intolerance.

Authors:  Julian M Stewart
Journal:  J Appl Physiol (1985)       Date:  2012-06-07

Review 9.  Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children.

Authors:  Julian M Stewart
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-11

Review 10.  Common syndromes of orthostatic intolerance.

Authors:  Julian M Stewart
Journal:  Pediatrics       Date:  2013-04-08       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.